Katherine Stueland, Chief Executive Officer at GeneDx Holdings Corp. (WGS), sold 23,274 shares at $89.44 ($2.2M) on 2025-03-13, disclosed to the SEC on 2025-03-17.
Open-market sale of $2.2M WGS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.44 | 1,078 | $96K | 4.3% |
| 2 | $89.44 | 1,078 | $96K | 4.3% |
| 3 | $96.71 | 10,559 | $1.0M | 45.7% |
| 4 | $96.71 | 10,559 | $1.0M | 45.7% |
| Total | $96.04 avg | 23,274 | $2.2M | 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |